Apollon Formularies (AQSE:APOL) Price-to-Operating-Cash-Flow : (As of Jun. 06, 2024)

View and export this data going back to . Start your Free Trial

What is Apollon Formularies Price-to-Operating-Cash-Flow?

As of today (2024-06-06), Apollon Formularies's share price is £8.0E-5. Apollon Formularies's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was £0.00. Hence, Apollon Formularies's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Apollon Formularies's Price-to-Operating-Cash-Flow or its related term are showing as below:

AQSE:APOL's Price-to-Operating-Cash-Flow is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 15.99
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Apollon Formularies's Cash Flow from Operations per share for the six months ended in Jun. 2023 was £0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was £0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 37.90% per year.

During the past 11 years, Apollon Formularies's highest 3-Year average Operating Cash Flow per Share Growth Rate was 37.90% per year. The lowest was 37.90% per year. And the median was 37.90% per year.

Apollon Formularies Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Apollon Formularies's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollon Formularies Price-to-Operating-Cash-Flow Chart

Apollon Formularies Annual Data

Trend

Jun10

Jun11

Dec12

Dec13

Dec14

Dec17

Dec18

Dec19

Dec20

Dec21

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Apollon Formularies Semi-Annual Data
	Jun11	Jun12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Jun23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial											-	-	-	-	-

Competitive Comparison of Apollon Formularies's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Apollon Formularies's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apollon Formularies's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Apollon Formularies's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Apollon Formularies's Price-to-Operating-Cash-Flow falls into.

Apollon Formularies Price-to-Operating-Cash-Flow Calculation

Apollon Formularies's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	8.0E-5	/	0
	=

Apollon Formularies's Share Price of today is £8.0E-5.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Apollon Formularies's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was £0.00.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Apollon Formularies Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Apollon Formularies's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Apollon Formularies (AQSE:APOL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Apollon Formularies PLC (AQSE:APOL) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Hope Street, Quayside House, Castletown, IMN, IM9 1AS

Website

https://www.apollon.org.uk

Apollon Formularies PLC is a London, England and Jamaican based medical cannabis pharmaceutical company specialising in research and treatment of patients with cancer and chronic pain. It is engaged in investing by seeking to acquire a direct and/or indirect interest in projects and assets in the agriculture and logistics sectors and the medicinal cannabis sector. The company focus on opportunities in Africa and Europe. It has created proprietary hybrid medical cannabis pharmaceutical strains, technology, formulations, and treatment products.